Author:
Jackson Shannon C,Yang Ming,Minuk Leonard,Sholzberg Michelle,St-Louis Jean,Iorio Alfonso,Card Robert,Poon Man-Chiu
Publisher
Springer Science and Business Media LLC
Subject
Hematology,Molecular Biology
Reference21 articles.
1. Iorio A, Marchesini E, Marcucci M, Stobart K, Chan AK. Clotting factor concentrates given to prevent bleeding and bleeding- related complications in people with hemophilia A or B. Cochrane Database Syst Rev. 2011;9:CD003429.
2. Srivastava A, Brewer AK, Mauser-Bunschoten EP, Key NS, Kitchen S, Llinas A, et al. Guidelines for the management of hemophilia. Haemophilia. 2013;19:e1–47.
3. Manco-Johnson MJ, Abshire TC, Shapiro A, Riske B, Hacker M, Kilcoyne RF, et al. Prophylaxis versus Episodic Treatment to Prevent Joint Disease in Boys with Severe Hemophilia. NEJM. 2007;357:535–44.
4. Carcao MD, Aledort L. Prophylactic factor replacement in hemophilia. Blood Rev. 2004;18:101–13.
5. Collins P, Faradji A, Morfini M, Enriquez MM, Schwartz L. Efficacy and safety of secondary prophylactic vs. on-demand sucrose-formulated recombinant factor VIII treatment in adults with severe hemophilia A: results from a 13-month crossover study. J Thromb Haemost. 2010;8:83–9.